Susquehanna International Group’s Genomic Health, Inc. GHDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-8,000
| Closed | -$543K | – | 11210 |
|
|
2019
Q3 | $543K | Sell |
8,000
-13,600
| -63% | -$934K | ﹤0.01% | 7121 |
|
|
2019
Q2 | $1.26M | Sell |
21,600
-11,200
| -34% | -$663K | ﹤0.01% | 5165 |
|
|
2019
Q1 | $2.3M | Buy |
32,800
+15,000
| +84% | +$1.11M | ﹤0.01% | 3540 |
|
|
2018
Q4 | $1.15M | Sell |
17,800
-5,000
| -22% | -$350K | ﹤0.01% | 4427 |
|
|
2018
Q3 | $1.6M | Buy |
22,800
+1,800
| +9% | +$105K | ﹤0.01% | 4358 |
|
|
2018
Q2 | $1.06M | Sell |
21,000
-36,700
| -64% | -$1.46M | ﹤0.01% | 5221 |
|
|
2018
Q1 | $1.8M | Buy |
57,700
+11,700
| +25% | +$388K | ﹤0.01% | 4111 |
|
|
2017
Q4 | $1.57M | Buy |
+46,000
| New | +$1.47M | ﹤0.01% | 4367 |
|
|
2017
Q3 | – | Sell |
-6,600
| Closed | -$215K | – | 10028 |
|
|
2017
Q2 | $215K | Sell |
6,600
-5,300
| -45% | -$168K | ﹤0.01% | 8173 |
|
|
2017
Q1 | $375K | Buy |
+11,900
| New | +$352K | ﹤0.01% | 7010 |
|
|
2016
Q1 | – | Sell |
-7,900
| Closed | -$278K | – | 10009 |
|
|
2015
Q4 | $278K | Buy |
+7,900
| New | +$212K | ﹤0.01% | 7834 |
|
|
2015
Q3 | – | Sell |
-7,200
| Closed | -$200K | – | 10509 |
|
|
2015
Q2 | $200K | Sell |
7,200
-11,600
| -62% | -$327K | ﹤0.01% | 9293 |
|
|
2015
Q1 | $574K | Buy |
18,800
+6,200
| +49% | +$197K | ﹤0.01% | 6838 |
|
|
2014
Q4 | $403K | Buy |
12,600
+2,100
| +20% | +$68.3K | ﹤0.01% | 7639 |
|
|
2014
Q3 | $297K | Buy |
10,500
+2,100
| +25% | +$58.5K | ﹤0.01% | 8046 |
|
|
2014
Q2 | $230K | Sell |
8,400
-53,100
| -86% | -$1.41M | ﹤0.01% | 8835 |
|
|
2014
Q1 | $1.62M | Buy |
61,500
+49,600
| +417% | +$1.42M | ﹤0.01% | 4677 |
|
|
2013
Q4 | $348K | Sell |
11,900
-10,300
| -46% | -$327K | ﹤0.01% | 7335 |
|
|
2013
Q3 | $679K | Buy |
22,200
+12,700
| +134% | +$425K | ﹤0.01% | 5955 |
|
|
2013
Q2 | $301K | Buy |
+9,500
| New | +$312K | ﹤0.01% | 6804 |
|
Susquehanna International Group's GHDX Position: Q4 2019 in Review
Susquehanna International Group sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 40,472 shares — an estimated $2.75M sold.
Susquehanna International Group first reported a position in GHDX in Q1 2014 and held it in 14 quarters. The position peaked at $2.87M in Q2 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.
- Susquehanna International Group reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
- Susquehanna International Group sold 40,472 Genomic Health, Inc. shares in Q4 2019, an estimated $2.75M.
- Susquehanna International Group first reported a position in Genomic Health, Inc. in Q1 2014 and held it in 14 quarters.
- Susquehanna International Group's Genomic Health, Inc. position peaked at $2.87M in Q2 2019.
- 0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.
Based on Susquehanna International Group's 13F filing for Q4 2019, filed 14 Feb 2020.